466 related articles for article (PubMed ID: 33687462)
21. Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis.
Moore TJ; Wirtz PW; Curran JN; Alexander GC
BMJ Open; 2023 Apr; 13(4):e069668. PubMed ID: 37094897
[TBL] [Abstract][Full Text] [Related]
22. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.
Maust DT; Kim HM; Chiang C; Kales HC
JAMA Intern Med; 2018 May; 178(5):640-647. PubMed ID: 29550856
[TBL] [Abstract][Full Text] [Related]
23. Predictors of CNS-Active Medication Use and Polypharmacy Among Homebound Older Adults With Depression.
Choi NG; Marti CN; Kunik ME
Psychiatr Serv; 2020 Aug; 71(8):847-850. PubMed ID: 32340595
[TBL] [Abstract][Full Text] [Related]
24. Trends in Number and Appropriateness of Prescription Medication Utilization Among Community-Dwelling Older Adults in the United States: 2011-2020.
Pan S; Li S; Jiang S; Shin JI; Liu GG; Wu H; Lyu B
J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38644631
[TBL] [Abstract][Full Text] [Related]
25. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly.
Weiner DK; Hanlon JT; Studenski SA
Gerontology; 1998; 44(4):217-21. PubMed ID: 9657082
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes.
Gerlach LB; Maust DT; Kales HC; Chang M; Kim HM; Wiechers IR; Zivin K
Am J Psychiatry; 2022 Aug; 179(8):544-552. PubMed ID: 35615813
[TBL] [Abstract][Full Text] [Related]
27. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
28. High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.
Silva Almodóvar A; Nahata MC
J Am Geriatr Soc; 2023 Jan; 71(1):98-108. PubMed ID: 36289563
[TBL] [Abstract][Full Text] [Related]
29. Use of antipsychotics among older residents in VA nursing homes.
Gellad WF; Aspinall SL; Handler SM; Stone RA; Castle N; Semla TP; Good CB; Fine MJ; Dysken M; Hanlon JT
Med Care; 2012 Nov; 50(11):954-60. PubMed ID: 23047785
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Concomitant Medications Prescribed with Antipsychotics to Patients with Dementia.
Saito Y; Oishi S; Takizawa T; Muraoka H; Yoshimura Y; Hashimoto I; Suzuki R; Ono T; Inada K
Dement Geriatr Cogn Disord; 2023; 52(4):222-231. PubMed ID: 37245511
[TBL] [Abstract][Full Text] [Related]
31. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
[TBL] [Abstract][Full Text] [Related]
32. [Rational use of psychotropic medications and sedative load in older adults with and without dementia].
Rattagan ML; Lisei D; Rojas GJ; Persi GG; Parisi VL; López Vicchi M; Da Prat de Magalhaes G; Bres Bullrich M; Gatto EM
Vertex; 2016 Sep; XXVII(129):332-338. PubMed ID: 28282070
[TBL] [Abstract][Full Text] [Related]
33. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
[TBL] [Abstract][Full Text] [Related]
34. Polypharmacy among older adults with dementia compared with those without dementia in the United States.
Growdon ME; Gan S; Yaffe K; Steinman MA
J Am Geriatr Soc; 2021 Sep; 69(9):2464-2475. PubMed ID: 34101822
[TBL] [Abstract][Full Text] [Related]
35. Frequency and Predictors of Polypharmacy in US Medicare Patients: A Cross-Sectional Analysis at the Patient and Physician Levels.
Ellenbogen MI; Wang P; Overton HN; Fahim C; Park A; Bruhn WE; Carnahan JL; Linsky AM; Balogun SA; Makary MA
Drugs Aging; 2020 Jan; 37(1):57-65. PubMed ID: 31782129
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.
Gerlach LB; Kales HC; Kim HM; Zhang L; Strominger J; Covinsky K; Teno J; Bynum JPW; Maust DT
J Am Geriatr Soc; 2021 Jun; 69(6):1479-1489. PubMed ID: 33683703
[TBL] [Abstract][Full Text] [Related]
37. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia.
Lau DT; Mercaldo ND; Harris AT; Trittschuh E; Shega J; Weintraub S
Alzheimer Dis Assoc Disord; 2010; 24(1):56-63. PubMed ID: 19561441
[TBL] [Abstract][Full Text] [Related]
38. Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD).
Vidoni ED; Kamat A; Gahan WP; Ourso V; Woodard K; Kerwin DR; Binder EF; Burns JM; Cullum M; Hynan LS; Vongpatanasin W; Zhu DC; Zhang R; Keller JN
J Alzheimers Dis; 2020; 77(1):175-182. PubMed ID: 32716358
[TBL] [Abstract][Full Text] [Related]
39. Polypharmacy and health beliefs in older outpatients.
Rossi MI; Young A; Maher R; Rodriguez KL; Appelt CJ; Perera S; Hajjar ER; Hanlon JT
Am J Geriatr Pharmacother; 2007 Dec; 5(4):317-23. PubMed ID: 18179989
[TBL] [Abstract][Full Text] [Related]
40. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
